ASPARGO LABORATORIES

aspargo-laboratories-logo

Aspargo Laboratories is a developer of an oral spray that treats erectile dysfunction.Spray formulation offers convenient drug administration, flexible-dose titration, and accessibility for patients with dysphagia (trouble swallowing). The company develops patient-focused solutions and medicines by combining their innovative science and technology. Its initial product candidate is a proprietary oral suspension spray formulation of sildenafil citrate, the active ingredient in VIAGRACurrently, it has approved for sale in 9 European countries and 8 Latin American countries, with pending approvals in Portugal, Mexico, Italy, Czech Republic, Slovak Republic, Greece, Australia, and China. Applications for approval are planned for Croatia, France, Germany, and Austria.

#SimilarOrganizations #People #Website #More

ASPARGO LABORATORIES

Social Links:

Industry:
Biopharma Biotechnology Medical Pharmaceutical

Founded:
2019-01-01

Address:
Englewood, New Jersey, United States

Country:
United States

Website Url:
http://www.aspargolabs.com

Total Employee:
1+

Status:
Active

Contact:
201-408-4831

Email Addresses:
[email protected]

Total Funding:
67.9 M USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API WordPress Font Awesome Cloudflare JS CDN JS Gravity Forms


Similar Organizations

aristea-therapeutics-logo

Aristea Therapeutics

Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases.

enterin-logo

Enterin

Philadelphia-based biotechnology company .

epivario-logo

EpiVario

EpiVario develops novel compounds to treat memory-related psychiatric disorders at the source of the disease.

eden-biologics-logo

Eden Biologics

Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.

lucaspye-bio-logo

LucasPye BIO

A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.

nephrodi-therapeutics-logo

NephroDI Therapeutics

NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.

halo-labs-logo

Halo Labs

Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.

trevarx-biomedical-logo

Trevarx Biomedical

Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.

Current Employees Featured

michael-demurjian_image

Michael Demurjian
Michael Demurjian Founder, Chairman and CEO @ Aspargo Laboratories
Founder, Chairman and CEO
2020-01-01

Founder


michael-demurjian_image

Michael Demurjian

Official Site Inspections

http://www.aspargolabs.com

  • Host name: 141.193.213.10
  • IP address: 141.193.213.10
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Aspargo Laboratories"

About โ€“ Aspargo Laboratories Inc.

The Global Leadership Team at Aspargo Labs consists of experts from the pharmaceutical, biotechnology, and consumer product industries. With decades of experience, in the development and commercialization of innovative โ€ฆSee details»

Aspargo Laboratories Inc. โ€“ Oral suspension โ€ฆ

Cookies are important to you because they affect your browsing experience and help protect your privacy. We use our own and third-party cookies to analyze our services and show you advertising that matches your preferences based on a โ€ฆSee details»

Investors โ€“ Aspargo Laboratories Inc.

Nov 19, 2024 Aspargo Labsโ€™ business model is repeatable and applies our proprietary technology to the worldโ€™s most meaningful compounds and brands. Current and near-term โ€ฆSee details»

Aspargo Laboratories - Crunchbase Company Profile

Contact Email [email protected] Phone Number 201-408-4831 Aspargo Laboratories is a developer of an oral spray that treats erectile dysfunction.Spray formulation offers convenient drug administration, flexible-dose titration, and โ€ฆSee details»

Aspargo Laboratories, Inc. | LinkedIn

Aspargo Laboratories, Inc. is a clinical-stage biopharmaceutical company developing patient-focused solutions and must-have medicines by combining our innovative science and technologies and FDA ...See details»

Aspargo Laboratories - PitchBook

Aspargo Laboratories General Information Description. Developer of an oral spray designed to treat erectile dysfunction. The company's oral spray is a formulation of sildenafil, the active ingredient in Viagra, enabling people with erectile โ€ฆSee details»

Aspargo Laboratories Inc. Announces Initial Dosing of All Subjects โ€ฆ

Sep 19, 2023 Cliantha Research, Aspargoโ€™s designated clinical contract research organization, is conducting the โ€œcrossoverโ€ study in 47 volunteers. Each subject is receiving ASP-001 and โ€ฆSee details»

Aspargo Laboratories Announces IND Clearance by U.S. FDA, โ€ฆ

Sep 5, 2023 Aspargo Laboratories, Inc. Company plans to initiate clinical trials in September 2023 to compare Sildenafil Oral Spray to Viagra® tablets, and effect of dose administration โ€ฆSee details»

Aspargo Labs

Weitere Informationen finden Sie auf unserer globalen Website: https://aspargolabs.com Therapietreue durch Hightech-Dispenser Aspargo Labs ist auch führend in der Entwicklung โ€ฆSee details»

Aspargo Laboratories Announces IND Clearance by U.S. FDA, โ€ฆ

Sep 5, 2023 Aspargo is the exclusive licensee of the patent rights covering Sildenafil Spray for the US and many international markets from Farmalider, S.A. (www.farmalider.com). For โ€ฆSee details»

Aspargo Labs Announces Data on First Oral Spray for Erectile ...

NEW YORK, July 30, 2024--Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a specialty pharmaceutical and MedTech company focused on transforming drug delivery with innovative โ€ฆSee details»

Aspargo Laboratories Announces IND Clearance by U.S. FDA

Sep 5, 2023 Aspargo Laboratories, Inc. announced today that it has received clearance of its Investigational New Drug (IND) application from the U.S. Food and Drug Administration (FDA) โ€ฆSee details»

Careers โ€“ Aspargo Laboratories Inc.

17 State Street, Suite 3220, New York, NY 10004 | 646-503-1260See details»

Aspargo Laboratories, Inc. Announces Successful Completion of โ€ฆ

May 4, 2020 Aspargo Laboratories, Inc. (Aspargo), a privately held, clinical stage pharmaceutical company, today announced the results of its pre-Investigational New Drug (pre โ€ฆSee details»

Aspargo Laboratories Announces IND Clearance by U.S. FDA,

Sep 5, 2023 1 1Rastrelli G, Maggi M. Erectile dysfunction in fit and healthy young men: psychological or pathological? Transl Androl Urol. 2017 Feb;6(1):79-90. doi: 10.21037/tau ...See details»

Aspargo Labs Appoints Chief Marketing Officer

Nov 19, 2024 [email protected]. Investor & media contacts: Russo Partners Nic Johnson or Liz Phillips (347) 956-7697. [email protected] โ€ฆSee details»

Aspargo Laboratories, Inc. - Facebook

Aspargo Laboratories, Inc. 46 likes. Aspargo Labs is a clinical-stage biopharmaceutical company developing patient-focused solutions andSee details»

Aspargo Laboratories, Inc. Announces Filing of Its Investigational โ€ฆ

Aug 1, 2023 Aspargo Laboratories, Inc. Planned bioequivalence study in healthy adult male subjects will compare the rate and extent of absorption of ASP-001 (Sildenafil Oral Spray) โ€ฆSee details»

Pipeline โ€“ Aspargo Laboratories Inc.

The creation of a next generation user-friendly oral medicine delivery device with mobile connectivity software. It will enable precise dosing and encourage adherence while providing โ€ฆSee details»

Aspargo Laboratories Inc. Announces Completion of Dosing of All ...

Dec 5, 2023 $99 Billion Bet: Warren Buffett Invests Heavily In 2 Stocks Expected To Jump 19% And 20%, Wall Street Analysts Predict. Warren Buffett's investment strategy is a case study in โ€ฆSee details»

linkstock.net © 2022. All rights reserved